RCE in Advantech Iview
CVE-2022-2143
The affected product is vulnerable to two instances of command injection, which may allow an attacker to remotely execute arbitrary code.
Vulnerability class: Command Injection (OS Command Injection)
EPSS: 0.592 (99.0th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.
Affected products
- Advantech Iview
- Advantech Iview — versions All
Weakness classification (CWE)
Public proof-of-concept exploits
References
- ics-cert@hq.dhs.gov (US Government Resource, Third Party Advisory, x_refsource_MISC)
- ics-cert@hq.dhs.gov (Exploit, VDB Entry, Third Party Advisory, x_refsource_MISC)
Frequently asked questions
- What is CVE-2022-2143?
- CVE-2022-2143 is a critical-severity vulnerability in Advantech Iview, classified under Command Injection. CVSS score: 9.8/10. Published 2022-07-22.
- How severe is CVE-2022-2143?
- Critical severity. CVSS v3 base score is 9.8 out of 10.
- Is CVE-2022-2143 known to be exploited?
- 4 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.